Insider Transactions in Q4 2022 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 28
2022
|
N Anthony Coles Director |
SELL
Open market or private sale
|
Direct |
5,758
-17.57%
|
$4,099,696
$712.52 P/Share
|
Dec 28
2022
|
N Anthony Coles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,758
+37.19%
|
$2,464,424
$428.4 P/Share
|
Dec 20
2022
|
P Roy Vagelos Director |
SELL
Discretionary transaction
|
Indirect |
141
-3.39%
|
$102,789
$729.29 P/Share
|
Dec 16
2022
|
P Roy Vagelos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,651
+0.51%
|
-
|
Dec 16
2022
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,926
+9.39%
|
-
|
Dec 16
2022
|
Robert E Landry EVP Finance CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,853
+10.5%
|
-
|
Dec 16
2022
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Grant, award, or other acquisition
|
Direct |
2,752
+10.64%
|
-
|
Dec 16
2022
|
Marion Mc Court EVP Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
2,973
+11.87%
|
-
|
Dec 16
2022
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
4,129
+6.36%
|
-
|
Dec 16
2022
|
Neil Stahl EVP Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,101
+2.03%
|
-
|
Dec 16
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Grant, award, or other acquisition
|
Direct |
3,798
+10.08%
|
-
|
Dec 12
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
264
-1.36%
|
$192,720
$730.17 P/Share
|
Dec 09
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-1.46%
|
$185,991
$753.28 P/Share
|
Dec 09
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.61%
|
$370,476
$753.28 P/Share
|
Dec 09
2022
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-0.89%
|
$350,898
$753.28 P/Share
|
Dec 09
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-0.86%
|
$370,476
$753.28 P/Share
|
Dec 09
2022
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
57
-0.02%
|
$42,921
$753.28 P/Share
|
Dec 09
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-2.36%
|
$370,476
$753.28 P/Share
|
Dec 09
2022
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
274
-1.39%
|
$206,322
$753.28 P/Share
|
Dec 09
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.67%
|
$370,476
$753.28 P/Share
|
Dec 08
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,261
-7.12%
|
$1,736,448
$768.54 P/Share
|
Dec 08
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+8.63%
|
$1,143,000
$381.92 P/Share
|
Dec 08
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
218
-16.77%
|
$169,822
$779.0 P/Share
|
Dec 08
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
218
+14.36%
|
$82,840
$380.95 P/Share
|
Dec 02
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
610
-0.69%
|
$462,380
$758.86 P/Share
|
Dec 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,890
-6.05%
|
$1,436,400
$760.35 P/Share
|
Dec 01
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.41%
|
$952,500
$381.92 P/Share
|
Dec 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$831,600
$756.19 P/Share
|
Dec 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$409,200
$372.46 P/Share
|
Dec 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$75,900
$759.98 P/Share
|
Nov 23
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
11,972
-2.31%
|
$8,871,252
$741.95 P/Share
|
Nov 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
38,028
-47.19%
|
$28,178,748
$741.81 P/Share
|
Nov 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+38.29%
|
$18,900,000
$378.98 P/Share
|
Nov 15
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,720
-0.31%
|
$2,715,600
$730.69 P/Share
|
Nov 14
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,280
-9.36%
|
$4,684,880
$746.0 P/Share
|
Nov 14
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.97%
|
$1,790,000
$179.13 P/Share
|
Nov 14
2022
|
Andrew J Murphy EVP Research |
SELL
Bona fide gift
|
Direct |
1,360
-2.33%
|
-
|
Nov 08
2022
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
330
-0.63%
|
-
|
Nov 08
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
500
-6.98%
|
$374,000
$748.49 P/Share
|
Nov 08
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,995
-12.02%
|
$3,032,205
$759.78 P/Share
|
Nov 08
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,995
+36.48%
|
$1,709,860
$428.4 P/Share
|
Nov 07
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
7,886
-3.72%
|
$5,875,070
$745.01 P/Share
|
Nov 04
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
26,114
-40.44%
|
$18,932,650
$725.84 P/Share
|
Nov 04
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
34,000
+34.49%
|
$12,954,000
$381.92 P/Share
|
Nov 04
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$727,000
$727.82 P/Share
|
Nov 04
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$372,000
$372.46 P/Share
|
Nov 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$75,500
$755.92 P/Share
|
Nov 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$825,000
$750.0 P/Share
|
Nov 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$409,200
$372.46 P/Share
|
Nov 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
482
-0.17%
|
$364,874
$757.9 P/Share
|